Pfizer is a multinational “big pharma” with deep scientific and commercialization expertise. While the COVID-related product tailwind has become a headwind of late, it still does not justify this low ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Donald Trump’s electoral victory has shaken the market, ...

COVID-19 continues to smolder around the edges of the benefits market, like hot ashes flickering around a poorly tended campfire. Executives from Pfizer, a pharmaceutical maker, said during a ...